These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 22072722

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparing the rubella seronegativity in pregnant women who received one dose of rubella vaccine at different ages in Taiwan.
    Shih CT, Chang YC, Wang HL, Lin CC.
    Vaccine; 2016 Sep 14; 34(40):4787-91. PubMed ID: 27544587
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rubella seroepidemiology among Korean women: Two decades after a combined vaccination strategy.
    Choe SA, Choe YJ, Paek JY.
    Int J Infect Dis; 2020 May 14; 94():25-28. PubMed ID: 32112963
    [Abstract] [Full Text] [Related]

  • 6. Seroprevalence of rubella among women of childbearing age in Taiwan after nationwide vaccination.
    Su SB, Guo HR.
    Am J Trop Med Hyg; 2002 Nov 14; 67(5):549-53. PubMed ID: 12479561
    [Abstract] [Full Text] [Related]

  • 7. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB, Kao CL, Lee CY.
    Southeast Asian J Trop Med Public Health; 1996 Dec 14; 27(4):707-14. PubMed ID: 9253871
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 13. [Avidity of immunoglobulin G to rubella virus in post-vaccination and post-infection immunity].
    Desiatskova RG, Zargar'iants AI, Stepanov AV, Zverev VV.
    Zh Mikrobiol Epidemiol Immunobiol; 2007 Apr 25; (4):6-11. PubMed ID: 17882830
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE, Kumar ML, Whitwell JK, Staehle BO, Rome LP, Dinakar C, Hurni W, Nalin DR.
    Pediatr Infect Dis J; 1996 Aug 25; 15(8):687-92. PubMed ID: 8858673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.